Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Orizuru Therapeutics, Inc. logo — R&D-driven company developing iPSCs to cure life-threatening...

Orizuru Therapeutics, Inc.

R&D-driven company developing iPSCs to cure life-threatening diseases with large unmet needs.

Founded 2021 Japan Japan 13 employees Biotechnology, Pharmaceutical

General Information

Company Name Orizuru Therapeutics, Inc.
Founded Year 2021
Location Japan Japan +1
Employees 13
Industries Biotechnology, Pharmaceutical
Social

Get notified when Orizuru Therapeutics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Orizuru Therapeutics, Inc.

Orizuru Therapeutics, Inc. is a promising R&D-driven startup with the noble goal of using induced pluripotent stem cell (iPSC) technology to develop groundbreaking regenerative medicine. Founded in 2021 as a spinout from Takeda Pharmaceuticals and Kyoto University, the company is dedicated to finding cures for life-threatening diseases with significant unmet needs. Operating in the Biotechnology and Pharmaceutical industries, Orizuru Therapeutics, Inc. holds immense potential in addressing critical medical challenges. As of now, specific headquarters location and investment details remain undisclosed, but the company's mission and roots in established institutions make it a compelling entity to watch in the biotech startup space.

Taxonomy: Regenerative Medicine, Induced Pluripotent Stem Cells, Life-Threatening Diseases, R&D, Stem Cell Therapy, Research and Development, Cell Therapy, Drug Development, Healthcare Innovation

No funding data available for Orizuru Therapeutics, Inc. yet.

Get notified when Orizuru Therapeutics, Inc. raises funding

Orizuru Therapeutics, Inc. Alternatives & Competitors

Orizuru Therapeutics, Inc. vs
eticur GmbH
eticur GmbH Germany

Mit eticur das Nabelschnurblut deines Kindes einlagern: Weil du entscheidest, wie Gesundheitsvorsorg...

5 employees
Biotechnology, Health and Wellness
Orizuru Therapeutics, Inc. vs
StemBioSys, Inc.
StemBioSys, Inc. United States

Making Cell Culture Relevant

Series B
11 employees
Biotechnology, Manufacturing
Orizuru Therapeutics, Inc. vs
TreeFrog Therapeutics
TreeFrog Therapeutics France

Cell Therapy for All

Debt Financing
177 employees
Biopharma, Biotechnology

FAQ About Orizuru Therapeutics, Inc.

R&D-driven company developing iPSCs to cure life-threatening diseases with large unmet needs.
Orizuru Therapeutics, Inc. was founded in 2021.
Orizuru Therapeutics, Inc. is headquartered in Japan.
Orizuru Therapeutics, Inc. operates in the following industries: Biotechnology, Pharmaceutical.
Orizuru Therapeutics, Inc. has approximately 13 employees.
Top alternatives and competitors to Orizuru Therapeutics, Inc. include eticur GmbH, StemBioSys, Inc., TreeFrog Therapeutics, Cell BioEngines, Inc, Medinno. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orizuru Therapeutics, Inc. and eticur GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Orizuru Therapeutics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes